Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Dirksen

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|August 8, 2019
Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcomaS E Bosma, A J Rueten-Budde, C Lancia, et al.
Blood|October 9, 1998
Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosisJ F Seymour, C G Begley, U Dirksen, et al.
Sarcoma|November 16, 2016
Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable ToxicityJ Herzog, F von Klot-Heydenfeldt, S Jabar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 11, 1999
Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center reportH J Laws, S Burdach, B van Kaick, et al.
BMC Cancer|October 24, 2025
OPTILATER: optimal long-term survival after cancer - a cross-sectional study protocol for a quantitative survey on the care situation of long-term cancer survivors in GermanyC N Martin, N De Lazzari, J Kersten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patientsT G P Grunewald, A Ranft, I Esposito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, AustriaS Burdach, B van Kaick, H J Laws, et al.
Oncogene|August 9, 2011
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcomaC Mackintosh, J L Ordóñez, D J García-Domínguez, et al.
Pediatric Blood & Cancer|June 6, 2013
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and AustriaC Rossig, H Juergens, M Schrappe, et al.
Bone Marrow Transplantation|January 30, 2021
No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced diseaseU Thiel, S J Schober, A Ranft, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|August 8, 2019
Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcomaS E Bosma, A J Rueten-Budde, C Lancia, et al.
Blood|October 9, 1998
Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosisJ F Seymour, C G Begley, U Dirksen, et al.
Sarcoma|November 16, 2016
Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable ToxicityJ Herzog, F von Klot-Heydenfeldt, S Jabar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 11, 1999
Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center reportH J Laws, S Burdach, B van Kaick, et al.
BMC Cancer|October 24, 2025
OPTILATER: optimal long-term survival after cancer - a cross-sectional study protocol for a quantitative survey on the care situation of long-term cancer survivors in GermanyC N Martin, N De Lazzari, J Kersten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patientsT G P Grunewald, A Ranft, I Esposito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, AustriaS Burdach, B van Kaick, H J Laws, et al.
Oncogene|August 9, 2011
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcomaC Mackintosh, J L Ordóñez, D J García-Domínguez, et al.
Pediatric Blood & Cancer|June 6, 2013
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and AustriaC Rossig, H Juergens, M Schrappe, et al.
Bone Marrow Transplantation|January 30, 2021
No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced diseaseU Thiel, S J Schober, A Ranft, et al.
Pageof 5